Eumed Biotechnology Co. Ltd. was established in January 2001. Developing of high quality biosensors and diagnostic reagent are our primary goals.Our team have gained many academic achievements in biotechnology and molecular biology for clinical applications even before founding of Eumed. It is our conviction to become one of the best Blood Glucose Monitoring System and diagnostic reagents manufacturer in the world.

Resulting from our research and development efforts, Eumed has introduced three products lines : Blood Glucose Monitoring System,cHPV Detection System and Safety Lancets system. Compared to the available self-monitoring blood glucose systems, our BGM delivers superior performance in accuracy, stability, speed and less sample volume. The cHPV Detection System was developed to detect human papilloma virus during screening for cervical cancer. Clinical trials have been completed with excellent results: our system achieved up to 98% sensitivity and accuracy. The one-time use Eusafe Safety lancets system quarantees to avoid cross-contanmination and accidental puncturing.

In addition to these two ready-to-use products, several new and innovative biosensors will be introduced onto the market in the near future.

 

January	2001	Eumed founded in Hsinchu, Taiwan by Tzer-Ming Chen MD, PhD
March	2002	Glucose Strip Pilot-Run Factory established in Jubei City, Taiwan
November	2002	Launching of the EUGLUCO blood glucose monitoring system at MEDICA 2002
April	2003	GMP Taiwan certification approval
May	2003	Launching of the EUSURE blood glucose monitoring system
June	2003	ISO 13485 certification (Total Quality System)
November	2003	CE Certificate & ISO 13485 approval
June	2005	Launching of the EUsafe safety lancet system
November	2005	Launching of the Eukare blood glucose monitoring system